Shari‘ah Treatment of Paradox between Access to Medicine and Global Pharmaceutical Patents under TRIPS Agreement 1994

Clicks: 2
ID: 311094
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #203 of 259 articles by views in Pakistan Journal of Islamic Research

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 259 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
This paper contributes to existing debate on issue of access to essential lifesaving medicine in result of global pharmaceutical patent protection standards. Application of Patent monopolies over pharmaceutical patents is very recent development under WTO regime. Considering pharmaceutical product as ordinary products and adoption of universal trade standards have resulted in high cost of lifesaving medicine which deprives poor masses around the world from enjoyment of life to health. Authorship on the subject has analysed the issue on jurisprudential, legal, and economic studies. A good number of Muslim countries put Islamic Shari‘ah on supra-constitutional level. This paper will interpret pharmaceutical patent right under Islamic Shari‘ah in post TRIPS Agreement developments.
Reference Key
imported_1769983603_697fce73aaf40 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rais Nouman Ahmed
Journal Pakistan Journal of Islamic Research
Year 2018
DOI
DOI not found
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.